2. Pizzi MA. Acute neurologic manifestations of respiratory viruses. Continuum (Minneap Minn) 2021;27(5):1365–1381.
3. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–690.
6. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–2270.
7. Chen X, Laurent S, Onur OA, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol 2021;268:392–402.
8. Misra S, Kolappa K, Prasad M, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology 2021;97:e2269–e2281.
11. Aladawi M, Elfil M, Abu-Esheh B, et al. Guillain Barre syndrome as a complication of COVID-19: a systematic review. Can J Neurol Sci 2022;49:38–48.
12. Chua TH, Xu Z, King NK. Neurological manifestations in COVID-19: a systematic review and meta-analysis. Brain Inj 2020;34:1549–1568.
13. Garg RK. Spectrum of neurological manifestations in Covid-19: a review. Neurol India 2020;68:560–572.
18. Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care 2021;34:139–143.
19. Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: is there a link? Epilepsia 2020;61:1840–1853.
20. Le Guennec L, Devianne J, Jalin L, et al. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia 2020;61:e90–e94.
23. Pellinen J, Carroll E, Friedman D, et al. Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia 2020;61:2097–2105.
26. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–998.
32. Cabezudo-García P, Ciano-Petersen NL, Mena-Vázquez N, Pons-Pons G, Castro-Sánchez MV, Serrano-Castro PJ. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology 2020;95:e1417–e1425.
33. Sanchez-Larsen A, Conde-Blanco E, Viloria-Alebesque A, et al. COVID-19 prevalence and mortality in people with epilepsy: a nation-wide multicenter study. Epilepsy Behav 2021;125:108379.
36. Zeng C, Meng H, Zhu Y, et al. Correlation of seizure increase and COVID-19 outbreak in adult patients with epilepsy: findings and suggestions from a nationwide multi-centre survey in China. Seizure 2021;88:102–108.
37. Huang S, Wu C, Jia Y, et al. COVID-19 outbreak: the impact of stress on seizures in patients with epilepsy. Epilepsia 2020;61:1884–1893.
41. Kuroda N, Kubota T. Psychological impact of the COVID-19 pandemic for patients with epilepsy: a systematic review and meta-analysis. Epilepsy Behav 2021;124:108340.
43. Hao X, Zhou D, Li Z, et al. Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China. Epilepsia 2020;61:1166–1173.
44. d'Orsi G, Mazzeo F, Ravidà D, et al. The effect of quarantine due to Covid-19 pandemic on seizure frequency in 102 adult people with epilepsy from Apulia and Basilicata regions, Southern Italy. Clin Neurol Neurosurg 2021;203:106592.
52. Lu L, Zhang Q, Xiao J, et al. COVID-19 vaccine take-up rate and safety in adults with epilepsy: data from a multicenter study in China. Epilepsia 2022;63:244–251.